Coupla million out of the blue, novartis starting PH2 should trigger close
to double digit milestone injection, it seems GSK doing a de facto PH2 on
colitis and psoriasis, who knows with them?.....Marc Voight, popping up
at the opening of an envelop with positive input....There is a confidence
exuding from the company that is slowly drifting into the market......
Top 20 hold 50%, forget about a takeover in my mind unless fair value
plus potential is factored, at this stage the potential is not quantiable
in my book......
Ann: Immutep receives A$1.9M from French R&D tax cash rebate, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.3¢ |
Change
0.003(0.81%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.3¢ | $303.4K | 981.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 102723 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 131156 | 19 |
View Market Depth
| Last trade - 10.58am 27/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
